NirtetralinCAS# 78185-63-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 78185-63-4 | SDF | Download SDF |
PubChem ID | 182644 | Appearance | Cryst. |
Formula | C24H30O7 | M.Wt | 430.5 |
Type of Compound | Lignans | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (5R,6S,7S)-5-(3,4-dimethoxyphenyl)-4-methoxy-6,7-bis(methoxymethyl)-5,6,7,8-tetrahydrobenzo[f][1,3]benzodioxole | ||
SMILES | COCC1CC2=CC3=C(C(=C2C(C1COC)C4=CC(=C(C=C4)OC)OC)OC)OCO3 | ||
Standard InChIKey | LHQDZANQXMRHIV-LZJOCLMNSA-N | ||
Standard InChI | InChI=1S/C24H30O7/c1-25-11-16-8-15-10-20-23(31-13-30-20)24(29-5)22(15)21(17(16)12-26-2)14-6-7-18(27-3)19(9-14)28-4/h6-7,9-10,16-17,21H,8,11-13H2,1-5H3/t16-,17-,21+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Nirtetralin suppresses effectively both HBsAg and HBeAg expression. |
Targets | HBV |
Nirtetralin Dilution Calculator
Nirtetralin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.3229 mL | 11.6144 mL | 23.2288 mL | 46.4576 mL | 58.072 mL |
5 mM | 0.4646 mL | 2.3229 mL | 4.6458 mL | 9.2915 mL | 11.6144 mL |
10 mM | 0.2323 mL | 1.1614 mL | 2.3229 mL | 4.6458 mL | 5.8072 mL |
50 mM | 0.0465 mL | 0.2323 mL | 0.4646 mL | 0.9292 mL | 1.1614 mL |
100 mM | 0.0232 mL | 0.1161 mL | 0.2323 mL | 0.4646 mL | 0.5807 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- YM155
Catalog No.:BCC2251
CAS No.:781661-94-7
- 4-Hydroxyisoleucine
Catalog No.:BCN1211
CAS No.:781658-23-9
- CDPPB
Catalog No.:BCC7610
CAS No.:781652-57-1
- MK-0974
Catalog No.:BCC1756
CAS No.:781649-09-0
- DAMGO
Catalog No.:BCC6958
CAS No.:78123-71-4
- Okadaic acid
Catalog No.:BCC2464
CAS No.:78111-17-8
- Aztreonam
Catalog No.:BCC2557
CAS No.:78110-38-0
- 2-Acetylfluorene
Catalog No.:BCC8516
CAS No.:781-73-7
- (R)-(+)-8-Hydroxy-DPAT hydrobromide
Catalog No.:BCC6929
CAS No.:78095-19-9
- Fmoc-Lys(Fmoc)-OH
Catalog No.:BCC3521
CAS No.:78081-87-5
- MMPX
Catalog No.:BCC6692
CAS No.:78033-08-6
- 1,3-Diacetylvilasinin
Catalog No.:BCN4580
CAS No.:78012-28-9
- 20(S)-Ginsenoside Rh2
Catalog No.:BCN1070
CAS No.:78214-33-2
- Paroxetine HCl
Catalog No.:BCC5054
CAS No.:78246-49-8
- [Orn5]-URP
Catalog No.:BCC5985
CAS No.:782485-03-4
- Hydroxysafflor yellow A
Catalog No.:BCN1049
CAS No.:78281-02-4
- Nepafenac
Catalog No.:BCC1258
CAS No.:78281-72-8
- Ecliptasaponin A
Catalog No.:BCN3843
CAS No.:78285-90-2
- 7-Ethylcamptothecin
Catalog No.:BCN2480
CAS No.:78287-27-1
- H-D-1-Nal-OH
Catalog No.:BCC3281
CAS No.:78306-92-0
- MRK 016
Catalog No.:BCC6070
CAS No.:783331-24-8
- MLN120B
Catalog No.:BCC1772
CAS No.:783348-36-7
- PCI-24781 (CRA-024781)
Catalog No.:BCC2155
CAS No.:783355-60-2
- Nocamycin I
Catalog No.:BCN1845
CAS No.:78339-49-8
Lignans with anti-hepatitis B virus activities from Phyllanthus niruri L.[Pubmed:22131154]
Phytother Res. 2012 Jul;26(7):964-8.
One new lignan, Nirtetralin B, along with its two known stereoisomers were isolated from Phyllanthus niruri L. The structure of the new compound was determined by spectroscopy experiments and x-ray diffraction analysis. These lignans were assayed for anti-hepatitis B virus activities in vitro. Nirtetralin and Nirtetralin A, B effectively suppressed the secretion of the HBV antigens in a dose-dependent manner with IC(5)(0) values for HBsAg of 9.5 microM (Nirtetralin A), 16.7 microM (Nirtetralin B) and 97.2 microM (Nirtetralin), IC(5)(0) values for HBeAg of 17.4 microM (Nirtetralin A), 69.3 microM (Nirtetralin B) and 232.0 microM (Nirtetralin), respectively.
Screening of 25 compounds isolated from Phyllanthus species for anti-human hepatitis B virus in vitro.[Pubmed:12748977]
Phytother Res. 2003 May;17(5):449-53.
Using an HBV-producing cell line and inhibition of the expression of the HBsAg and HBeAg as antiviral indicators, a study was conducted on 25 compounds isolated from four Phyllanthus (Euphorbiaceae) plants, including P. amarus Schum. & Thonn., P. multi florus Willd., P. tenellus Roxb. and P. virgatus Forst. f. It was found that niranthin (1), Nirtetralin (3), hinokinin (5) and geraniin (13) at the non-cytotoxic concentration of 50 micro m, suppressed effectively both HBsAg and HBeAg expression, with the highest inhibition at 74.3%, 45.3%; 69.6%, 33.9%; 68.1%, 52.3%; 32.1%, 46.6%, respectively. Of these, niranthin (1) showed the best anti-HBsAg activity, while the most potent anti-HBeAg activity was observed with hinokinin (5).